Esidrix, Hydrodiuril, Microzide, Oretic, Rasilez (hydrochlorothiazide) is a small molecule pharmaceutical. Hydrochlorothiazide was first approved as Esidrix on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against solute carrier family 12 member 3. In addition, it is known to target glutamate receptor 2.
|Trade Name||Rasilez HCT|
|Indication||edema, heart failure, hypertension, nephrotic syndrome|
|Drug Class||Diuretics (thiazide derivatives)|